Effect of serum creatinine on efficacy and prognosis of cardiac resynchronization therapy

WANG Dong-mei,HAN Ya-ling,ZANG Hong-yun,YU Hai-bo,ZHANG Dong-hong,WANG Shou-li,WANG Zu-lu
2011-01-01
Abstract:Objective To assess the influence of the level of serum creatinine(SCr) before implantation on the prognosis of patients with cardiac resynchronization therapy(CRT). Methods Ninty-one patients with heart failure were divided into three groups(Group Ⅰ: SCr≤1.0mg/dl,n=33;Group Ⅱ: 1.1 mg/dl < SCr ≤1.5 mg/dl,n=35;Group Ⅲ: 1.5 mg/dl <SCr ≤2.5 mg /dl,n=23).Results There were 6 patients(18.18%) died in Group I and 7(20%) died in Group Ⅱ and 8(34.78%) died in Group Ⅲ.The heart function improved significantly after 6 and 12 months of operation in 3 groups(P<0.01).6-minute hall-walking test increased significantly in Group I and Group II(P<0.01)and did not increase significantly in Group Ⅲ(P>0.05)at 6~12 months of postoperation.Left ventricular end-diastolic dimension diminished significantly at the 6~12 month follow-up in Group I(P<0.05~0.01) and did not decrease obviously in Group Ⅱ and Ⅲ(P>0.05).Left ventricular ejection fraction increased significantly in 3 Groups(P<0.05~0.01).There was significantly statistical difference in 3 Groups.Conclusion The higher level SCr(>1.5 mg/dl) before implantation predicts worse left ventricular remodeling and the increase of patients′ mortality from heart failure aggravation after CRT implantation.
What problem does this paper attempt to address?